By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synapse Biomedical 

300 Artino Street

Oberlin  Ohio  44074  U.S.A.
Phone: 440-774-2488 Fax: 440-774-2572


Medical Device

Company News
Synapse Biomedical Release: U.S. ALS Diaphragm Pacing Study Showing Safety And Benefit Trend Is Suspended Due To Slow Recruitment 9/22/2015 1:06:49 PM
Synapse Biomedical Release: Multi-Center ALS Study Using The NeuRx Diaphragm Pacing System (DPS) Shows Safety And Survival Post-Implant Of 20.9 Months 8/26/2015 6:22:43 AM
Synapse Biomedical Release: A Decade of NeuRx DPS Use: Analysis Of Diaphragm Pacing In 214 Patients With Lou Gehrig's Disease (ALS) Shows Safety And Improved Survival Benefit 8/12/2015 7:45:03 AM
Synapse Biomedical Announces The Early Completion Of Enrollment In The FDA Post Approval Study For ALS Patients 9/30/2014 7:47:40 AM
Ohio Pours Millions Into Device Companies- List Includes Synapse Biomedical, Intellirod Spine, Cleveland Medical Devices Inc., And Nanofiber Solutions 12/30/2013 9:20:25 AM
Synapse Biomedical Receives Canadian Health Ministry Approval Of NeuRx Diaphragm Pacing System (DPS)® For Spinal Cord Injury Breathing Applications 11/13/2013 11:32:29 AM
Synapse Biomedical to Add 60 New Jobs in Expansion 6/26/2012 8:19:36 AM
Synapse Biomedical Receives FDA Approval for NeuRx Diaphragm Pacing System (DPS)(R) to Treat Amyotrophic Lateral Sclerosis (ALS) 9/29/2011 11:34:15 AM
Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 10/8/2010 11:05:10 AM
Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury 6/18/2008 8:13:14 AM